• Home
©2023 - The Better Parent. All Right Reserved. Designed & Developed by Theory Solutions

Researchers solve mystery of how ALL enters the central nervous system

by Staff July 18, 2018
July 18, 2018 62 views
62

A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system. ALL in the central nervous system is very difficult to treat, because most drugs are blocked from the organ system due to a “blood-brain barrier” designed to protect the brain. How cancer cells enter the central nervous system has been an unanswered question for researchers and clinicians for decades. A research team has now found that this blood cancer infiltrates the central nervous system not by breaching the blood-brain barrier, but by evading the barrier altogether.

Source: sciencedaily.com

ScienceDaily
0 FacebookTwitterPinterestEmail
previous post
7 Helpful Websites for Learning About the Countries of the World
next post
Google Assistant Can Now Help You Plan Your Day

Related Posts

Temperature of a rocky exoplanet measured

March 27, 2023

Bomb-sniffing rodents undergo ‘unusual’ reproductive transformations

March 27, 2023

The Greenland Ice Sheet is close to a...

March 27, 2023

Beneficial bacteria in the infant gut uses nitrogen...

March 27, 2023

Colorful films could help buildings, cars keep their...

March 27, 2023

New ways to measure curls and kinks could...

March 27, 2023

Trending

  • 3 Ways to Edit the boot/config.txt File on Raspberry Pi

    August 30, 2018
  • 6 Tools to Sync Microsoft Outlook With Google Calendar

    January 7, 2019
  • How to Vectorize an Image in Adobe Illustrator

    March 29, 2019
  • What Does This Emoji Mean? Emoji Face Meanings Explained

    May 24, 2019
  • The 7 Best DIY Security Camera Apps and Software for Linux

    May 31, 2019

©2023 - The Better Parent. All Right Reserved. Designed & Developed by Theory Solutions

Related Articlesx

Toward principles of gene regulation in multicellular...

Brain disease transmitted by tick bites may...

PARP inhibitor shrinks tumors in pancreatic cancer...